Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001956111 | SCV002240835 | pathogenic | not provided | 2021-11-14 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Arg1946Leufs*22) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 22135276). |
Baylor Genetics | RCV003475242 | SCV004200676 | pathogenic | Retinitis pigmentosa 39 | 2023-06-13 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005008305 | SCV005638633 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2024-03-29 | criteria provided, single submitter | clinical testing |